72 related articles for article (PubMed ID: 22996770)
1. [Myeloid-derived suppressor cells in patients with breast cancer].
Gonda K; Shibata M; Ohtake T; Yasuda M; Abe N; Watanabe K; Ando J; Okano M; Onozawa H; Tachibana K; Ohto H; Takenoshita S
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1363-8. PubMed ID: 22996770
[TBL] [Abstract][Full Text] [Related]
2. Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.
Hock BD; Mackenzie KA; Cross NB; Taylor KG; Currie MJ; Robinson BA; Simcock JW; McKenzie JL
Nephrol Dial Transplant; 2012 Jan; 27(1):402-10. PubMed ID: 21617199
[TBL] [Abstract][Full Text] [Related]
3. Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer.
Ohki S; Shibata M; Gonda K; Machida T; Shimura T; Nakamura I; Ohtake T; Koyama Y; Suzuki S; Ohto H; Takenoshita S
Oncol Rep; 2012 Aug; 28(2):453-8. PubMed ID: 22614133
[TBL] [Abstract][Full Text] [Related]
4. [Myeloid-derived suppressor cells in cancer patients].
Gonda K; Shibata M; Nakamura I; Kenjo A; Ohtake T; Yasuda M; Suzuki S; Suzuki H; Watanabe T; Fujimori K; Gotoh M; Takenoshita S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1797-9. PubMed ID: 23267890
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cells in human peripheral blood: Optimized quantification in healthy donors and patients with metastatic renal cell carcinoma.
Flörcken A; Takvorian A; Singh A; Gerhardt A; Ostendorf BN; Dörken B; Pezzutto A; Westermann J
Immunol Lett; 2015 Dec; 168(2):260-7. PubMed ID: 26462434
[TBL] [Abstract][Full Text] [Related]
6. [Changes in myeloid-derived suppressor cells in malignant effusions of cancer patients following cancer chemotherapy].
Gonda K; Shibata M; Shimura T; Abe N; Suzuki S; Yasuda M; Nakamura I; Ohtake T; Ohki S; Watanabe T; Fujimori K; Suzuki S; Ohto H; Takenoshita S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2088-91. PubMed ID: 23267986
[TBL] [Abstract][Full Text] [Related]
7. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
Mandruzzato S; Solito S; Falisi E; Francescato S; Chiarion-Sileni V; Mocellin S; Zanon A; Rossi CR; Nitti D; Bronte V; Zanovello P
J Immunol; 2009 May; 182(10):6562-8. PubMed ID: 19414811
[TBL] [Abstract][Full Text] [Related]
8. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells.
Luyckx A; Schouppe E; Rutgeerts O; Lenaerts C; Fevery S; Devos T; Dierickx D; Waer M; Van Ginderachter JA; Billiau AD
Clin Immunol; 2012 Apr; 143(1):83-7. PubMed ID: 22341087
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy.
Diaz-Montero CM; Salem ML; Nishimura MI; Garrett-Mayer E; Cole DJ; Montero AJ
Cancer Immunol Immunother; 2009 Jan; 58(1):49-59. PubMed ID: 18446337
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
11. Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue.
Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Petersen-Baltussen HM; ter Laan M; Wesseling P; Adema GJ
J Neuropathol Exp Neurol; 2015 May; 74(5):390-400. PubMed ID: 25853692
[TBL] [Abstract][Full Text] [Related]
12. [Levels of myeloid-derived suppressor cells in peripheral blood of infants with recurrent wheezing].
Wang XF; Han Y; Zhang YL; Song L; Xu CN
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1116-8. PubMed ID: 24342211
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck.
Hoffmann TK; Müller-Berghaus J; Ferris RL; Johnson JT; Storkus WJ; Whiteside TL
Clin Cancer Res; 2002 Jun; 8(6):1787-93. PubMed ID: 12060618
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
Sinha P; Clements VK; Fulton AM; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4507-13. PubMed ID: 17483367
[TBL] [Abstract][Full Text] [Related]
15. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.
Idorn M; Køllgaard T; Kongsted P; Sengeløv L; Thor Straten P
Cancer Immunol Immunother; 2014 Nov; 63(11):1177-87. PubMed ID: 25085000
[TBL] [Abstract][Full Text] [Related]
16. Myeloid cells in circulation and tumor microenvironment of breast cancer patients.
Toor SM; Syed Khaja AS; El Salhat H; Faour I; Kanbar J; Quadri AA; Albashir M; Elkord E
Cancer Immunol Immunother; 2017 Jun; 66(6):753-764. PubMed ID: 28283696
[TBL] [Abstract][Full Text] [Related]
17. The Measure of DAMPs and a role for S100A8 in recruiting suppressor cells in breast cancer lung metastasis.
Vrakas CN; O'Sullivan RM; Evans SE; Ingram DA; Jones CB; Phuong T; Kurt RA
Immunol Invest; 2015; 44(2):174-88. PubMed ID: 25255046
[TBL] [Abstract][Full Text] [Related]
18. Detection of tumor cells in the bone marrow, peripheral blood, and apheresis products of breast cancer patients using flow cytometry.
Simpson SJ; Vachula M; Kennedy MJ; Kaizer H; Coon JS; Ghalie R; Williams S; Van Epps D
Exp Hematol; 1995 Sep; 23(10):1062-8. PubMed ID: 7544737
[TBL] [Abstract][Full Text] [Related]
19. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
[TBL] [Abstract][Full Text] [Related]
20. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
